Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.78
Delayed Data
As of Feb 16
 -0.02 / -1.11%
Today’s Change
1.69
Today|||52-Week Range
7.10
-11.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash18.7M9.8M10.2M11.6M
 
 
 
 
 
Short Term Investment Cash5.2M-8.9M373.2K1.4M
 
 
 
 
 
Cash & Short Term Investments18.8M32.7M23.4M20.3M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.000.00--
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses507.2K--501.2K179.5K
 
 
 
 
Other Current Assets0.00731.0K720.6K429.0K
 
 
 
 
Current Assets19.3M33.4M24.7M20.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross645.9K687.2K749.5K758.1K
 
 
 
 
 
Depreciation-580.7K-609.1K-636.6K-669.5K
 
 
 
 
 
Other Assets0.000.000.0030.8K
 
 
Total Assets19.6M33.5M24.8M21.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable251.7K706.8K774.5K0.00
 
 
 
 
Accrued Expenses240.6K1.1M1.6M641.1K
 
 
 
 
 
Other Current Liabilities240.6K1.1M1.6M1.1M
 
 
 
 
 
Other Liabilities933.8K2.5M2.7M1.9M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities5.1M3.9M2.8M1.7M
 
 
 
 
 
Total Liabilities6.9M7.0M6.0M4.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity12.6M26.6M18.8M17.1M
 
 
 
 
 
Total Shareholder Equity12.6M26.6M18.8M17.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding14.7M17.8M19.7M23.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.